Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004194155 | SCV003693374 | uncertain significance | not specified | 2022-11-30 | criteria provided, single submitter | clinical testing | The c.4530C>G (p.C1510W) alteration is located in exon 32 (coding exon 31) of the ADCY10 gene. This alteration results from a C to G substitution at nucleotide position 4530, causing the cysteine (C) at amino acid position 1510 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003410204 | SCV004116259 | likely benign | ADCY10-related disorder | 2024-07-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |